Patrick Gallagher resigned as a director of Protea Biosciences Group Inc.
Gallagher's resignation was not the result of a dispute or disagreement with the company.
Protea Biosciences board member resigns
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Patrick Gallagher resigned as a director of Protea Biosciences Group Inc.
Gallagher's resignation was not the result of a dispute or disagreement with the company.